Literature DB >> 3029294

Synthesis in Escherichia coli and immunological characterization of a polypeptide containing the cleavage sites associated with trypsin enhancement of rotavirus SA11 infectivity.

C F Arias, M Lizano, S López.   

Abstract

About 45% of the rotavirus SA11 VP3 gene was inserted into a thermoinducible expression plasmid under the control of phage lambda PL promoter. The primary translation product predicted on the basis of the plasmid construction was a hybrid protein in which the 98 amino-terminal amino acids of phage MS2 polymerase were followed by amino acids 42 to 387 of the VP3 protein, which included the region containing the cleavage sites associated with trypsin enhancement of infectivity. On induction, a polypeptide that had the expected mol. wt. and contained VP3-related amino acid sequences as judged by immunological criteria, was synthesized to a level representing about 15% of the total bacterial protein. When a bacterial lysate enriched for the fusion polypeptide was injected into mice, it induced antibodies which inhibited haemagglutination and neutralized SA11 rotavirus infectivity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029294     DOI: 10.1099/0022-1317-68-3-633

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  21 in total

1.  VP7 mediates the interaction of rotaviruses with integrin alphavbeta3 through a novel integrin-binding site.

Authors:  Selene Zárate; Pedro Romero; Rafaela Espinosa; Carlos F Arias; Susana López
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

2.  Priming for rotavirus neutralizing antibodies by a VP4 protein-derived synthetic peptide.

Authors:  C F Arias; G Garcia; S Lopez
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

Review 3.  Rotavirus gene structure and function.

Authors:  M K Estes; J Cohen
Journal:  Microbiol Rev       Date:  1989-12

4.  Further antigenic characterization of porcine rotavirus YM.

Authors:  C F Arias; A M Ruiz; S López
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

5.  Functional and topographical analyses of epitopes on the hemagglutinin (VP4) of the simian rotavirus SA11.

Authors:  J W Burns; H B Greenberg; R D Shaw; M K Estes
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

6.  Serotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children.

Authors:  G Menchaca; L Padilla-Noriega; M Méndez-Toss; J F Contreras; F I Puerto; H Guiscafré; F Mota; I Herrera; R Cedillo; O Muñoz; R Ward; Y Hoshino; S López; C F Arias
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

7.  Rotavirus infection activates dendritic cells from Peyer's patches in adult mice.

Authors:  Delia V Lopez-Guerrero; Selene Meza-Perez; Oscar Ramirez-Pliego; Maria A Santana-Calderon; Pavel Espino-Solis; Lourdes Gutierrez-Xicotencatl; Leopoldo Flores-Romo; Fernando R Esquivel-Guadarrama
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

8.  The amino-terminal half of rotavirus SA114fM VP4 protein contains a hemagglutination domain and primes for neutralizing antibodies to the virus.

Authors:  M Lizano; S López; C F Arias
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

9.  The peptide-binding and ATPase domains of recombinant hsc70 are required to interact with rotavirus and reduce its infectivity.

Authors:  Jimena Pérez-Vargas; Pedro Romero; Susana López; Carlos F Arias
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

10.  Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates.

Authors:  Xiaobo Wen; Dianjun Cao; Ronald W Jones; Jianping Li; Shousun Szu; Yasutaka Hoshino
Journal:  Vaccine       Date:  2012-08-09       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.